Skip to main content

Breadcrumb

  1. Home

Clinician: Group/Practice

Valid for Measure Submission

Hospital-Wide 30-Day, All-Cause, Unplanned Readmission Rate (HWR) for the Merit-Based Incentive Payment System (MIPS) Eligible Clinician Groups

  • The 30-day Hospital-Wide, All-Cause Unplanned Readmission (HWR) Rate for the Merit-based Incentive Payment System (MIPS) Groups measure is a risk-standardized readmission rate for beneficiaries age 65 or older who were hospitalized and experienced an unplanned readmission for any cause to a short-stay acute-care hospital within 30 days of discharge. The measure attributes readmissions to up to three MIPS participating clinician groups, as identified by their Medicare Taxpayer Identification Number (TIN), and assesses each group’s readmission rate.

    CBE ID
    3495

Hydroxychloroquine annual eye exam

  • This measure identifies the percentage of patients with Rheumatoid Arthritis who received hydroxychloroquine during the measurement year and had a fundoscopic examination during the measurement year or in the year prior to the measurement year

    CBE ID
    0585

Inappropriate Pulmonary CT Imaging for Patients at Low Risk for Pulmonary Embolism

  • Percent of patients undergoing CT pulmonary angiogram for the evaluation of possible PE who are at low-risk for PE consistent with guidelines(1,2) prior to CT imaging.

    (1) Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008 Sep;29(18):2276-315

    CBE ID
    0667

Influenza Immunization

  • Percentage of patients aged 18 years and older with a diagnosis of ESRD and receiving dialysis who received the influenza immunization during the flu season (September through February)

    CBE ID
    0227

Informed, Patient Centered (IPC) Hip and Knee Replacement Surgery

  • The measure is derived from patient responses to the Hip or Knee Decision Quality Instruments. Participants who have a passing knowledge score (60% or higher) and a clear preference for surgery are considered to have met the criteria for an informed, patient-centered decision.
    The target population is adult patients who had a primary hip or knee replacement surgery for treatment of hip or knee osteoarthritis.

    CBE ID
    2958

Ischemic Vascular Disease (IVD): Blood Pressure Control

  • The percentage of patients 18 to 75 years of age who were discharged alive with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had the following during the measurement year:

    - Blood pressure control (BP): reported as under control <140/90 mm Hg.

    CBE ID
    0073

Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control &lt;100 mg/dL

  • The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) during the 12 months prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to measurement year, who had each of the following during the measurement year.

    - Complete Lipid Profile
    - LDL-C control <100 mg/dL

    CBE ID
    0075